Home/Filings/4/0001209191-21-057708
4//SEC Filing

WHITFIELD ROY A 4

Accession 0001209191-21-057708

CIK 0000906709other

Filed

Sep 23, 8:00 PM ET

Accepted

Sep 24, 6:16 PM ET

Size

8.9 KB

Accession

0001209191-21-057708

Insider Transaction Report

Form 4
Period: 2021-09-22
Transactions
  • Award

    Common Stock

    2021-09-22+10,200236,050 total
  • Award

    Stock Option

    2021-09-22+20,40020,400 total
    Exercise: $17.78Exp: 2029-09-21Common Stock (20,400 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    51,500
  • Common Stock

    (indirect: By Trust)
    20,000
Footnotes (3)
  • [F1]Common stock was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.
  • [F2]This RSU award vests in full, one year following September 22, 2021.
  • [F3]This stock option vests in equal monthly installments over the one-year period beginning on September 22, 2021.

Issuer

NEKTAR THERAPEUTICS

CIK 0000906709

Entity typeother

Related Parties

1
  • filerCIK 0000936728

Filing Metadata

Form type
4
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 6:16 PM ET
Size
8.9 KB